JCR Pharmaceuticals (DB:JCR) - Stock Price, News & Analysis

JCR Stock Overview

Engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan.

About the company

JCR fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	1/6
Past Performance	2/6
Financial Health	5/6
Dividends	5/6

Rewards

Trading at 30.8% below our estimate of its fair value

Earnings are forecast to grow 7.93% per year

Earnings have grown 7.7% per year over the past 5 years

Pays a reliable dividend of 2.95%

Risk Analysis

No risks detected for JCR from our risk checks.

JCR Pharmaceuticals Co., Ltd. Competitors

PharmaSGP Holding

XTRA:PSG

€280.6m

Dermapharm Holding

XTRA:DMP

€1.8b

Pierrel

DB:2FJ0

€92.8m

MPH Health Care

DB:93M1

€103.6m

Price History & Performance

Summary of all time highs, changes and price drops for JCR Pharmaceuticals
Historical stock prices
Current Share Price	JP¥4.08
52 Week High	JP¥4.20
52 Week Low	JP¥3.94
Beta	0.056
11 Month Change	0.99%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	1.49%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	JCR	DE Pharmaceuticals	DE Market
7D	3.0%	4.6%	1.2%
1Y	n/a	-8.0%	16.6%

Return vs Industry: Insufficient data to determine how JCR performed against the German Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how JCR performed against the German Market.

Price Volatility

Is JCR's price volatile compared to industry and market?
JCR volatility
JCR Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	8.1%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	11.0%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: Data is not available.

Volatility Over Time: Insufficient data to determine JCR's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1975	934	Shin Ashida	www.jcrpharm.co.jp

JCR Pharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease.

JCR Pharmaceuticals Co., Ltd. Fundamentals Summary

How do JCR Pharmaceuticals's earnings and revenue compare to its market cap?
JCR fundamental statistics
Market cap	€521.77m
Earnings (TTM)	€25.23m
Revenue (TTM)	€247.52m

20.7x

P/E Ratio

2.1x

P/S Ratio

Is JCR overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
JCR income statement (TTM)
Revenue	JP¥40.21b
Cost of Revenue	JP¥10.33b
Gross Profit	JP¥29.88b
Other Expenses	JP¥25.78b
Earnings	JP¥4.10b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Oct 30, 2024

Earnings per share (EPS)	32.83
Gross Margin	74.31%
Net Profit Margin	10.19%
Debt/Equity Ratio	50.7%

How did JCR perform over the long term?

See historical performance and comparison

Dividends

2.9%

Current Dividend Yield

61%

Payout Ratio

Does JCR pay a reliable dividends?

See JCR dividend history and benchmarks

When do you need to buy JCR by to receive an upcoming dividend?
JCR Pharmaceuticals dividend dates
Ex Dividend Date	Sep 27 2024
Dividend Pay Date	Dec 09 2024
Days until Ex dividend	22 days
Days until Dividend pay date	51 days

Does JCR pay a reliable dividends?

See JCR dividend history and benchmarks